Use of Commercial anti‐CD19 CAR T Cell Therapy for...

  • Main
  • 2020 / 08
  • Use of Commercial anti‐CD19 CAR T Cell Therapy for...

Use of Commercial anti‐CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

Sesques, Pierre, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Tordo, Jérémie, Dhomps, Anthony, Karlin, Lionel, Brisou, Gabriel, Vercasson, Marlène, Hospital‐Gustem, Carole, Schwiertz, V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25951
Date:
August, 2020
File:
PDF, 1.41 MB
2020
Conversion to is in progress
Conversion to is failed